Journal: Current Protein & Peptide Science
Guest editor(s):Dr. Hao Chi
Co-Guest Editor(s): Ke Xu,Miguel Pereira-Silva,Guanhu Yang

Introduction

The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay between cancer cells and the immune system. By doing so, it seeks to facilitate the identification of new therapeutic targets and biomarkers, which could significantly enhance the precision and effectiveness of cancer treatments. We welcome submissions from a broad range of disciplines including oncology, immunology, proteomics, peptidomics, and bioinformatics. This interdisciplinary approach is crucial for tackling the various challenges associated with cancer therapy, from understanding the underlying mechanisms of immune evasion to the development of more targeted and individualized treatment options. Through this thematic issue, we aim to foster collaboration among researchers and clinicians, encouraging the exchange of ideas and findings that could lead to groundbreaking advancements in immunotherapy. Ultimately, this issue aspires to contribute to the improvement of patient outcomes and the advancement of cancer treatment methodologies worldwide.

Keywords

Cancer Immunotherapy, Proteomics, Peptidomics, Tumor Immune Microenvironment, Therapeutic Targets, Biomarkers, Oncology, Bioinformatics

Sub-topics

Advances in Proteomic Techniques for Cancer Immunotherapy

Peptidomic Profiling of the Tumor Immune Microenvironment

Identification and Validation of Novel Immunotherapeutic Targets

Biomarker Discovery in Cancer Immunotherapy Using Proteomics

Role of Peptidomics in Understanding Tumor-Immune System Interactions

Integrative Bioinformatics Approaches for Proteomic and Peptidomic Data

Case Studies on the Clinical Application of Proteomics in Immunotherapy

Cross-disciplinary Innovations: Combining Oncology, Immunology, and Bioinformatics